Oxalic Acid

Oxalic Acid

SCHEMBL7347292

O=C(O)C(=O)O.c1cc(CCC2CCC3(CC2)CCC(OCCN2CCCC2)CC3)co1

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
OPRM1 known ✓ P35372 4/20 0.37
LTA4H P09960 1/20 0.40
OPRD1 P41143 4/20 0.37
OPRK1 P41145 4/20 0.37
HTT P42858 1/20 0.35
KDM4E B2RXH2 6/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 2/20 0.34
ITGB3 P05106 1/20 0.34
ITGA2B P08514 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33
BLM P54132 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7337662 0.94 LTA4H (0.44) LTA4HOPRM1OPRD1OPRK1NPC1
SCHEMBL7346567 0.88 LTA4H (0.40) LTA4HHTR2C
SCHEMBL7348815 0.86 LTA4H (0.35) LTA4HOPRM1OPRD1OPRK1ALDH1A1
SCHEMBL7340174 0.86 LTA4H (0.35) LTA4HOPRM1OPRD1OPRK1NPC1
SCHEMBL7347297 0.83 LTA4H (0.37) LTA4HOPRM1OPRD1OPRK1NPC1
SCHEMBL7342835 0.81 LTA4H (0.42) LTA4HOPRM1OPRD1OPRK1ALDH1A1
SCHEMBL7338815 0.80 HTT (0.43) HTTKDM4ESMN1; SMN2ALDH1A1
SCHEMBL7341504 0.79 LTA4H (0.42) LTA4HOPRM1OPRD1OPRK1ALDH1A1
SCHEMBL7339312 0.79 NR1H4 (0.34)
SCHEMBL7341051 0.76 NR1H4 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0578080-B1 3,9-disubstituted-spiro (5.5)undecanes active on the cardiovascular system, process for their preparation and pharmaceutical composition containing same SIGMA TAU IND FARMACEUTI (IT) 1997-04-23 EP disclosed
US-5444082-A Treats hypertension and heart failure SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 1995-08-22 US disclosed
EP-0578080-A2 3,9-disubstituted-spiro (5.5)undecanes active on the cardiovascular system, process for their preparation and pharmaceutical composition containing same Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 1994-01-12 EP disclosed